Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.

A new series of amphiphilically modified chitosan molecules with long alkyl chains as hydrophobic moieties and glycol groups as hydrophilic moieties (N-octyl-O-glycol chitosan, OGC) was synthesized for use as drug carriers. The chemical structure was characterized by Fourier transform infrared, (1)H nuclear magnetic resonance, and elemental analysis. OGC could easily self-assemble to form nanomicelles in an aqueous environment and exhibited a low critical micellar concentration of 5.3-32.5mg/L. The biocompatibility and low toxicity of OGC as excipient for the dosage forms aimed at i.v. administration were confirmed by hemolysis, acute toxicity and histopathological studies. Furthermore, the possibility of solubilizing paclitaxel (PTX), a water-insoluble antitumor drug, with OGC micelles was also explored. PTX was successfully loaded into OGC micelles by using a simple dialysis process. The drug-loading capacity of OGC and stability of drug-loaded micelles were significantly affected by the degree of substitution of alkyl chains. Moreover, a series of safety studies including hemolysis, hypersensitivity, maximum tolerated dose, acute toxicity, and organ toxicity revealed that the PTX-loaded OGC micelles had advantages over the commercially available injectable preparation of PTX (Taxol((R))), in terms of low toxicity levels and increased tolerated dose. Additionally, cytotoxicity studies showed that the PTX-loaded OGC micelles were comparable to the commercial formulation, but the blank micelles were far less toxic than the Cremophor EL vehicle. These results suggest that OGC is a promising carrier for injectable PTX micelles.

[1]  Hsing-Wen Sung,et al.  In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. , 2002, Biomaterials.

[2]  Cecilia Díaz,et al.  Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines. , 2006, International journal of pharmaceutics.

[3]  Hyesung Jeon,et al.  Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[5]  W. Hunter,et al.  Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel , 1999 .

[6]  S. Feng,et al.  Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Hyun-Jin Park,et al.  O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acid-modified chitosan in the aqueous system. , 2003, Journal of agricultural and food chemistry.

[8]  Ling Wang,et al.  Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin. , 2009, Colloids and surfaces. B, Biointerfaces.

[9]  Hesson Chung,et al.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Kinam Park,et al.  Hydrotropic polymer micelle system for delivery of paclitaxel. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Xu Xiangyang,et al.  Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity. , 2007, Colloids and surfaces. B, Biointerfaces.

[12]  J. Leroux,et al.  Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[13]  K. De Yao,et al.  Self-aggregation behavior of alkylated chitosan and its effect on the release of a hydrophobic drug , 2003, Journal of biomaterials science. Polymer edition.

[14]  S. Armes,et al.  New folate-functionalized biocompatible block copolymer micelles as potential anti-cancer drug delivery systems , 2006 .

[15]  C. I. Bliss THE CALCULATION OF THE DOSAGE-MORTALITY CURVE , 1935 .

[16]  Yung-Chih Wu,et al.  A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Yue’e Fang,et al.  Synthesis of a novel chitosan derivative having poly (ethylene oxide) side chains in aqueous reaction media , 2005 .

[18]  P. Caliceti,et al.  Poly(hydroxyethylaspartamide) derivatives as colloidal drug carrier systems. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Xiao-bing Xiong,et al.  Polymeric micelles for drug targeting , 2007, Journal of drug targeting.

[20]  Mitchell A. Winnik,et al.  Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study , 1991 .

[21]  A. Miwa,et al.  Development of Novel Chitosan Derivatives as Micellar Carriers of Taxol , 1998, Pharmaceutical Research.

[22]  S. Zeng,et al.  Novel self-aggregates of chitosan oligosaccharide grafted stearic acid: preparation, characterization and protein association. , 2006, Die Pharmazie.

[23]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[24]  Yogesh Kadam,et al.  Solubilization of poorly water-soluble drug carbamezapine in pluronic micelles: effect of molecular characteristics, temperature and added salt on the solubilizing capacity. , 2009, Colloids and surfaces. B, Biointerfaces.

[25]  Yongzhong Wang,et al.  Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105/L101 mixed polymeric micelles. , 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[26]  M. Brewster,et al.  Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  A. Fahr,et al.  Drug delivery strategies for poorly water-soluble drugs , 2007, Expert opinion on drug delivery.

[28]  Yujiang Fan,et al.  Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  J. Xue,et al.  Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. , 2007, Biomaterials.

[30]  C. van Nostrum,et al.  The effect of core composition in biodegradable oligomeric micelles as taxane formulations. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  Xiguang Chen,et al.  Linolenic acid-modified chitosan for formation of self-assembled nanoparticles. , 2005, Journal of agricultural and food chemistry.

[32]  Eun-Mi Kim,et al.  Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system. , 2009, International journal of pharmaceutics.

[33]  Gregory F. Payne,et al.  Enzymatic gelation of the natural polymer chitosan , 2000 .

[34]  A Senso,et al.  Characterization of doubly substituted polysaccharide derivatives. , 2000, Carbohydrate research.

[35]  Yi Jin,et al.  Doxorubicin-Loaded Polymeric Micelles Based on Amphiphilic Polyphosphazenes with Poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide) and Ethyl Glycinate as Side Groups: Synthesis, Preparation and In Vitro Evaluation , 2009, Pharmaceutical Research.

[36]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[37]  Jianping Zhou,et al.  Potential of amphiphilically modified low molecular weight chitosan as a novel carrier for hydrophobic anticancer drug: Synthesis, characterization, micellization and cytotoxicity evaluation , 2009 .

[38]  J. Welsh,et al.  Self‐Assembled Poly(butadiene)‐b‐poly(ethylene oxide) Polymersomes as Paclitaxel Carriers , 2007, Biotechnology progress.

[39]  I. Kwon,et al.  Complex formation between plasmid DNA and self-aggregates of deoxycholic acid-modified chitosan , 2005 .

[40]  I. Kwon,et al.  Structural determination and interior polarity of self-aggregates prepared from deoxycholic acid-modified chitosan in water , 1998 .

[41]  Ick Chan Kwon,et al.  Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Henrik Gréen,et al.  Comparison of two types of population pharmacokinetic model structures of paclitaxel. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[43]  J. Remon,et al.  Paclitaxel/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion - formulation and stability. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[44]  J. Pawliszyn,et al.  Determination of free concentration of Paclitaxel in liposome formulation. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[45]  Can Zhang,et al.  Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system. , 2004, Colloids and surfaces. B, Biointerfaces.

[46]  Hong Yuan,et al.  Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[47]  Lichen Yin,et al.  Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs. , 2009, Biomacromolecules.

[48]  Ick Chan Kwon,et al.  Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic Acid , 2003 .

[49]  I. Kwon,et al.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel , 2003 .

[50]  J Verweij,et al.  Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.

[51]  Sung Chul Kim,et al.  Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles. , 2005, International journal of pharmaceutics.

[52]  Ick Chan Kwon,et al.  Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. , 2009, Biomaterials.

[53]  Hong Yuan,et al.  PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[54]  B. Stanford,et al.  A review of clinical experience with paclitaxel extravasations , 2003, Supportive Care in Cancer.

[55]  Tatsuhiro Yamamoto,et al.  Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[57]  S. Zeng,et al.  A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. , 2006, International journal of pharmaceutics.

[58]  R. Liggins,et al.  Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. , 2002, Advanced drug delivery reviews.

[59]  D. Braguer,et al.  Seventy‐two‐hour stability of Taxol® in 5% dextrose or 0·9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non‐PVC bags , 2005, Journal of clinical pharmacy and therapeutics.

[60]  J. Schneider,et al.  Self-assembling materials for therapeutic delivery. , 2009, Acta biomaterialia.

[61]  Hong Yuan,et al.  Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery. , 2009, Journal of pharmaceutical sciences.

[62]  Tetsuro Tanaka,et al.  Synthesis and evaluation of water-soluble poly(vinyl alcohol)-paclitaxel conjugate as a macromolecular prodrug. , 2008, Biological & pharmaceutical bulletin.

[63]  Kwangmeyung Kim,et al.  Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. , 2005, Biomacromolecules.

[64]  조원호,et al.  Structural determination and interior polarity of self-aggregates prepared from deoxycholic acid-modified chitosan in water , 1998 .

[65]  San-Yuan Chen,et al.  Synthesis and characterization of amphiphatic carboxymethyl-hexanoyl chitosan hydrogel: water-retention ability and drug encapsulation. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[66]  S. Zeng,et al.  Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. , 2006, Colloids and surfaces. B, Biointerfaces.